GSK Approves Buyback at Rs 800

The board of drugmaker GlaxoSmithKline Pharmaceuticals told the BSE on Tuesday that it had approved a buyback of shares at up to Rs 800 per share. The total buyback would be of up to a quarter of its total equity capital and would not exceed Rs 231 crore, the notice said.

The Economic Times (http://economictimes.indiatimes.com/articleshow/1052046.cms)